← Leaderboards
Noah Lechtzin
Johns Hopkins University
$2,564,678
Attributed
$4,452,382
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $809.7K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,432,858 · 2
FDA$19,524 · 1
By mechanism
R01$3,794,932 · 2
K23$657,450 · 1
Top collaborators
- Christopher Hooper Goss5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A. Wise$33,179,807
- Hendree E. Jones$34,132,831
- Pamela L. Zeitlin$9,680,949
- Hyder A Jinnah$25,307,523
- Nadia N Hansel$30,283,781
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeClinical TrialsEmergency SituationAdherence (Attribute)AnxietyEarly TreatmentCare DeliveryComputerizedCare SeekingCaringChronic Obstructive Airway DiseaseClinical CareAdolescentBaseAdultCoughingCystic FibrosisData CollectionData ExchangeDepressive SymptomsDiagnosisDyspneaEarly IdentificationAcute
Grant awards (11)
Ph 1-2 Study of Glycerolphenylbutyrate for Cystic Fibrosis IND 125,124 (12/5/15)$19,524
R01 · FY2016 · FD · contact PI
Early Intervention in Pulmonary Exacerbation in CF$717,087
R01 · FY2014 · HL
Early Intervention in Pulmonary Exacerbation in CF$706,945
R01 · FY2013 · HL
Early Intervention in Pulmonary Exacerbation in CF$761,712
R01 · FY2012 · HL
Early Intervention in Pulmonary Exacerbation in CF$779,929
R01 · FY2011 · HL
Early Intervention in Pulmonary Exacerbation in CF$809,735
R01 · FY2010 · HL
Improving Respiratory Outcomes in ALS$131,490
K23 · FY2006 · HL · contact PI
Improving Respiratory Outcomes in ALS$131,490
K23 · FY2005 · HL
Improving Respiratory Outcomes in ALS$131,490
K23 · FY2004 · HL
Improving Respiratory Outcomes in ALS$131,490
K23 · FY2003 · HL
Improving Respiratory Outcomes in ALS$131,490
K23 · FY2002 · HL